Bacterin reports outcomes of two-year research for OsteoSponge Bacterin International Holdings.

The analysis in addition has been accepted for display at the 2012 AAOS Annual Meeting in SAN FRANCISCO BAY AREA, On February 7-11 California, 2011.. Bacterin reports outcomes of two-year research for OsteoSponge Bacterin International Holdings, Inc. Found in conjunction with the sufferers’ personal bone marrow aspirate, OsteoSponge is an efficient osteoinductive and osteoconductive bone scaffold that supports spinal fusion. The study was executed in collaboration with experts at the Salt Lake Orthopaedic Clinic, Spine Medical procedures of Salt Lake Town.Thomson’s laboratory, strong intellectual property and licensed patents from many universities exclusively, CDI is rolling out a proprietary process in which it offers industrialized the manufacture of human cells cells in high quantity, purity and quality. Stem cell technology provides significant potential to boost human health, stated James A. Thomson, Ph.D. Related StoriesPublic policy needed to reduce stem cell tourism, say expertsUS and German experts team up to progress quality control of human stem cellsKey protein handles stem cell properties that will make them useful in regenerative medicineRobert Palay, ceo of CDI, continued, The technology out of Dr.